KRAS and lung adenocarcinoma: To determine if there is evidence for such a promotional activity in the selection of oncogenic KRAS mutations in humans, we extracted the mutation signatures in the COSMIC database [27, 34] for human KRAS-mutant lung adenocarcinomas.